Vaccine Messaging By the FDA: A National Randomized Survey Study

In a national survey of public attitudes toward vaccination, respondents were more likely to get a well-tested vaccine with demonstrated safety and efficacy over a vaccine that had been quickly tested, irrespective of whether vaccine development was announced by the FDA or the President. This suggests that political interference may need to be more explicit before it alters public trust in the FDA’s vaccine approval process.